Inhibition of Enzymes Which Interact with Citrate by (-)-Hydroxycitrate and 1,2,3-Tricarboxybenzene by Leznoff, Clifford C. et al.
Inhibition of Enzymes which fnteract with Citrate
by (-)Hydroxycitrate and 1,2,3,-Tricarboxyb ernene
Surinder Csnnu^4.-Dseor,r, Mitchell L. H.l'rrssnr and. Clifford, C. Lrznorr
Doparbmont of trfodicino, Uuiversity of Tomnto, and Depa,r0ment of Ctemist'ry, YorL University, Donaeview
The efreots of two citrate analoguea, (-)hyclroxycitrate and 1,2,3-tricarboxybenzene, wero
studied using rat liver enz5mes which interaot with citrato.
The most pronounced efect of 1,2,3-triaarboxybenzene was inhibition of acetyl-CoA oarboxyl-
ase (trr 20 pU). It algo inhibited t'he mitochondrial citrate transportor (60Y0 inhibition at 3 mM),
but was uot a substrato for this transporter.
ATP-sitrate lyaso was markedly inhibited by both free (-)hyclroxyoitrate (K1 8 p,M) ancl(-)hydroxyoifrato lactone (&50 to 100 pM). Acetyl.CoA carboxylase was activated by both the
forms of (-)hydroxycitrato (K, 0.7 mM and 1.6 mM, respectively). (-)Eydrorycitrato is a sub-
etrato for ihe mitochondrial citrate transporter, but its rate of tuaneport is lesg than 100/o ofthat
of sitrate.
Other cit'late metabolizing enzJmes also were inhibited by 1,2,3-tnicarboxybenzene and(-)hydroxyoitrate but much higher concentnations were required.
The importance of citnate as a regulator and sub-
strate in intermediary metabolism has received
considerable attention. It is an intermediate in tho
tricarboxylio aoid cycle and in t'he pathway for bio-
synthesis of lipids. ft is an inhibitor of phospho-
fruotokinase [1-3] and, thereforo, a potontial regu-
lator of glycolysis. Activation of acotyl-CoA carboxyl-
aee [4-6] by citrato may stimulate the fatty acid
biosynthetic pathway. Citrato has also beon shown
to inhibit pynrvate dehydrogenase p,8], an action
which could limit p5rmvate oxidation in fasting.
Two analogues of cit'rate which inhibit speoific
steps in sitrate metabolism have recently been re-
ported [9,10]. (-)Eydroxycitrate is an inbibitor of
ATP-citrate lyase t9] and 1,2,3-tricarboxybenzene is
an inhibitor of t'he mitochondriel citrato tranrporter
[10]. We havo studied tho efrects of these inhibitors
on the enzJmes and transport system known to be
involved in the intermediary metaboligm of citrate.
These studies were underteken to allo$/ more rational
interpretation of their effects in biologioal systems,
IIATER.I.IIIS AND METEODS
Male Wista,r rats weighing 110-150 g were fed
ad, I,ibi,tum,anl[saariff.c€d. ( 
-)Eydroxycitrate lactone
was a kind gift from Dr Y. S. Lewis (Mysore, fndia).
1,2,3-Tbicarboxybenzene was obtained. from K. and
K. Laboratories (Plainview, N. Y.). [1-u0]Pyruvate
and sodium [u0]bica,rbonate were purchased. from
Amershan-Searle (Don Mills, Ontario). Aldolase,
glycerol-l-phosphate dehydrogenase, triosephosphate
isomeraso, NADP+-linked ieocitrate dehydrogenase,
metabolic intermediates and the pyridine nucleot'ides
were obtained. from Boehringer Mannheim GmbE
(New York, N.Y.). Aoetyl-CoA and bovine serum
albumin were obtained from Sigma Chemical Co.
(St. Louis, Missouri) a,nd coenzyme A was obtained
from Calbioohem (Ioa Angeles, Califomia),
Pregnrati,on anil Aeaoy of Enzgmcs lrmn Bat Liaer
Protein was det€rminecl by tho method of 'War-
burg and Christian [11] or Lowry et al.lI?l. Enzymes
were used for kinetio studies within 1-2 days after
t'heir preparation.
Ci,trate synllwse was preparecl up to tho first
(NE4)aS0{ fractionation with a specific activity of
0.63 unitslmg protein, and assayed. by the method
of Shepherd and Garland [13].
Enzgmt*. Acotyl-0oA ca,rborylaae (DC 0.4.1.2); citrato-
(isocitrate)hydro-lyase or aconiteso (EC 4.2.1.3) ; ATP-oit'rato
lya"ee (EC 4.1.3.8); cit'rato synthaso (EC a.1.3.7); NAD-ieo-
citrato debydrogenase (EC 1.1.1.41); NADP-isocitrat€ de-
hydnogenaso (EC 1. 1. 1.42) ; phosphofr uctokinase (EC 2.7. 1. I I )
pyruvato dehydrogonaso (DC 1.2.4.1).
Aeoni,tase was prepared by the method. of Faneler
and Lowenstein [14], with slight modifications. Iho
intnamitochondrial enz5nne was obtained by suspend-
ing a mitochondrial pellet [15] in four timeg its
volume of 15 rqM tricarballylatre-Tris bufer, pI[ ?.S.
The suspension was sonicated at 20kEzls for 8 min(6-10 'C). Insoluble material was removed by oentri-
fugation at 130fr)xg for 16min. Solid (NH.LSOI
was added to the supematant to 500/o of saturation.
After centrifugation at 13000x9 for 16min the
precipitate waa disaerded and the supornatant assa,y-
ed for aaonitas€ aativity. The enz5rme had a speciffa
activity of ?4 units/mg protein. The kinetic pa,ram-
etors were determined using a spectrophotometrio
assay [14] or a fluorometrio a,ssay ooupling this rea,o-
tion to NADP+-linked isocitrate dehydrogenaso.
ATP-aitrqte Lgase ww purified to tho 26-$0la
(NE1)sSOr fractionation with a specifio aotivity of
0.39 unit/mg protein by the method of Takedq d al.
and assayed fluorometrically [16].
NADP+-l,i,nheil, i,soai,trate ilnh,yd,rogenase (intra-
mitoohondrial and extnamitoohondrial) was purified
as follows. Rat livers were homogenized in 0.1 M
potassium phosphate bufer pH 7.6 containing 0.5 M
sucrose and centrifuged at 10CIx9 for 10 min. The
supernatant was centrifuged again for 10 min at
13000x9 to obtain a mitochondrial pellet. This
pellet was suspended in 3 volumes of 0.1 M potassium
phosphate buffer pE 7.6, sonicat€d. at Z}kHzls
for 6min (5-10"C) and contrifugect at 13000xgfor 30 min. Dithiothreitol (0.3 nM) and EDTA
(1 mM) were added to this supernatant, then (NHr)u-
SOa was added. to 500/6 saturation, After centri-
fugation at 10000xg for 16min, the pellet was
discarded and additional ammonium sulphate added
to 800/0 of satuation. Aftor centrifugation, the preci-
pitate was dissolvod in a minimnm yolume of 0.1 M
Tris.HCl pH 7.4 containing 0.3 mM dithiothreitol
and 1 mM EDTA. The specifio activity of the enz5rme
was 203 unitslmg protein. The supernatant obtained
from the initial 13000xg centrifugation w&s centni-
fuged again at 106000xg for 60min. A 60-800/o
ammonium sulphato fractionation was oarried out,
as just deecribed for the soluble mitoohondrial
enzyme, to a specific activity of 330 unite/mg protein.
Both enzymes were assayd fluorinetrically tl7].
NAD+-linkeil iaacdtrqte il,ehyilrogmaa€ wa,s prepar-
ed from rat liver mitoahondria (specific activity
17 unitslmg) and assayed as described by Martin
and Denton [17].
Acefgl,-CoA m,rborglnse was assayed in an 80000
Xg supernatant by tho godi"m [raC]bicorbonate ffxa-
tion method [18].
Phnsphnfruftokinax ww prepared as o 30-d00/o(NE4)'SO1 fraction (specifio activity 7.9 units/mg
protein) by the method of Kemp [19], with the
exception that the heat step was omitted. ft was
assayed fluorometrically [3].
7.
Pyuuate d,ehgil,rogenase was assayed in rat liver
mitoohondria aftcr homogsniza,Niss of the mito-
chondrial pellet in h5rpotonio solution (10 mM potas-
siun phosphate, lmM EDTA, 1mM dithiothreitol,
10/o fatty-acid-poor bovino serum albumin, pH 7.4)
t201.
M i,toahffid,rial,-trtoa,rbouylnte-axclw,n4e ohtd,iu werc
oarried out using the methods of Robinson et al. l2Ilfor both fa0loitrate loading and [lr0]citratelcitrate
exohanges.
Ilw Purifiari,an, ol ( 
-)Eyilrorgcitrda Aoiil,(-)Hydroxycitrio acid was dissolved in ether
and. filtered. to remove insoluble impuritiet, Puriffed(-)hydroxyoit'ric acid laatone, m.p. 178 oC, w&s
reorystallized from ether as described by Lewis and
Neelakanton [22]. Aqueous solutions of potaasium
sslts of the free acid were obtained by roising the
pH to 12 with KOII for 10 min at 26 oC prior to
neutnalization.
1 unit of enz5me activity is deffned as the amount
causing t'ransformation of l pmol substrate per min
ai 260"C under optimal oonditions of measuremont.
&AsI'LTS AND DISCUSSION
Phaaplnlrudokinase
As shown previously [1 
-3], citrato inhibited.phosphofructokinaso (Tablo 1). Phosphofruotokinase
was also inhibited by 1,2,3-tricarboxybenzene and(-)hyclroxycitrate, but tho ooneentrations required
for 500/o deoreaso in aotivity were approxim&tely
l.Z-fold greater than for cituato (3.9 mM) (Table 1).
AutyL"CoA Carborgla*e
Activation of acetyl.CoA oarboxylaae by citrato
was inhibited by 1,2,3-trioarboxybenzeno is a mannor
aompetitive with citrate ('K1 approx. 20pM, X'ig. 1).
In the absenoo of oitrate, 1,2,3-trioarborybenzene
lad no effect. (-)Eydroxycitrate activated acetyl-CoA carboxylaso (X'ig.2), as reported. proviously
123,2A7.
The M itoahond,rial, T riaarbouglate C ani,er
and tlw, Irtuami,toahan d,ri,al, Emyrmu
Previous studies have shovrn that 1.,2,3.tri-
carboxybenzene is a competitive inhibitor of oitrate
t'ransport in rat-liver mitochondria with a Kr of
3mM [10] (Table2B). (-)Hydroxyoitrato did not
inhibit the oarrier but was a weak substrato. the.K-
a,ppea,rs to bo of the same order of magnitude as
that for oitrato, but the 7 was much lower (Table 2A).
As a weak substrato for this oarrier, (-)hyilroxy-
oitlate may enter tho mitochondria wbere it could
affect the intramitochondrial citrate-rnetabolizing
enzJrmes. Xlee (-)hydroxycitrate inhibiteil intra-
Table 1. Ellcnta ol cihale, 7,2,3-tricarboxgbennnc M (-)hC.
ilrorgcitrale on, plnephofrtwblciwe lron nt liuer
Tho assay mixture (1 rnl) contoinod 0.1 M Tris.ECl pE 7.0,
0.03 nM EDTA, 10.0 mM MgOlr, 0.06 mM NADII, 0.06 mM
dithiothroitol, 0.01 M NII4CI, 0.2 mM ATP, 0.9 mM fructoso.
6-phosphate, 30 pg aldolase, 6 pg glycerol-phosphato do-
hydrogenaso and 6 pg trioaephosphate isomersse in addition
to the extraot fron rat livor. The reaction was start€al bv t'be
addition of fructos€ 6-phoaphate. Each assay was etudih in
duplieato wing six conoentrations of each inhibitor
Addltlon to
s8soy mixturo
ConooDtrotlon for
50 r/o lnhlbltion
Cit'rato
1,2,3-Trioa,rborrybonzene
( 
- 
)Ilydmxycitnato (free)(-)Hydmxycitrate
(lactone)
Tabls2. Ellect of citr&, (-)hyilrocyaitrote and 7,2,3-tri-
ilrbotgbetuzetue on the, mitachpnd,rial aitrate tranxporter ol ral-
liaer mitoalwil,rio
fncubations were performed at 8 oC as doscribed by Robinson
et al. [2L1. Tho exchanges were st&rt€d by the addition of
[uC]oitrateJoaded mitochondria. Aftnr 46 s, citrato tnansport
waa terminote4 by lhu rapid addition of 1,2,3-tricarboxy-benzeno (50 mM). The conetente roported were colculated
from Lineweaver-Burk plote, usiug 7 concentrationg ofesoh
eubgtroto
A
Eig.t. Diron Sot ta clwt tlw ellect of T,2,S.tricarborgbewntw
on oilrate.aatiualed a,cetgl-CoA u,rboxglue aalhrlty. Acetyl-
CoA oarborylaso was assayod by tho [t{C]bicorbonate fixation
assay [18]. Supornatant (0.02 ml) was preincubated at 37 oC
for 30 min in tho preaenoe of potasaium oitrate. The preincu-
bation mixturo also contained 60 nM Tris-HCl pII 7.5,
20 mM MgCt, 1.0 mM 2-mer.captoet'hanol, and 0.9 mg/ml
bovine gsrum albumin in a total volume of 0.7 ml. The reac-
tion was sterted by adding 0.40mM NaHlaCO, (10-pCi),
2 mM ATP, and 0.14 mM acetyl-CoA to the preincubation
mixturo and thon incubatcd for 2 min. Volocity (o) was
msasurcd as NaIIlaCO" 6nal (nmol min-l pg-r). 1,2,3-Tli-
oa,rboxybonzono (inhibitor) was added to the proincubation
mirture in the presence of potassium citrato, 3 mllf (r) anit
z mM (o)
ml}f
3.9
4.7
5.0
3.6
Aililttton Rqto of cltrete
exohange, Pnu
o.r o"2 0.3
[tntrititor] lmrty
o-4 0.5 0.6
5.0
Citrat€
(-)Eytlrorycitrato(tuo)
(-)Hydrnxycitrate
(lactone)
mM
o.22
0.35
0.30
nmolxmin-rxmg
protela-!
3.5 to 8.0 (12)
0.32
o.L7
B
Additlon T\ma of CoDooutrotlon
.-1ii;.,-- roquhed for
50.[ tnhlbliion
Citrato * 1,2,$.tri-
oorboxybenzene
Citrote * (-)hyrlroxy-
oitrato (free)
Citrate { (-)hydrory-
citrato (lactone)
mitochondrial NADP+-linked isocitrate dehyclro-
genase with a Kr of 0.26 mM and aaonitose with a
Kr of 0.28 mM (Table 3). Intramitoohondrial a,conit-
ase wa,s also inhibited by (-)hydroxyoitrate laotone(/(r O.g mM). Neithor (-)hydroxyoitrato nor 1,2,3-
tricarboxybenzene inhibited the NAD+-linked iso-
citreto dehydrogenase. In faot, slight activation of
1 .O 3.O
t/[ectivatorJ (mm-r)
Eig.Z. Ellect of citratc ann (-)ltgilrorgaitrale on aaetyl-CoA
mrboxylase actititg lron ral Lhnr. Conditions of assay wero
thoeo ilescribed for Fig.l. Tho J(n valueg wore calculated to
be 6.7 mM for citrate (o-a) and 0.7 mM for free (-)hy-
drcxycitrato (O----O). Not shown in the figure, the frn
for tho laotone (-)hydroxycitrate was 1.6 mM
this enzyme by (-)hydroryoitrate was observed a,t
low isooitrate concentr&tions. This onzyme ca,n also
bo activated by citrato 126-271. Tho Kr va,lues for
the other intramitochondrial enzymes that a,re in-
hibited by these compounds &re yery high (Table 3),
oompetitive
no inhibition
no inhibition
s.0
Table 3. Kt taluee tor inhibllitn bg ( 
-)hgdrooyaitrate and, 1,2,8-tritnrborybenem,e ol enzgmc with aitrale and, ieocitrale as &rbEtmte
or prdunt
lhe va,rious onzymes were arsayed ag descrlbed in Methods. The kinetic constanta were caloulated from Dixon plots using a
minimum of six inhibitor ooncentrations
(-)Eyilroxyoitrato
(ftee)
(-)Eydroryoitrete 1,2,3.&i-(lactons) ea,rboxybenzene
Citrato synthaso
Aoonitaso
Citrete lyase
Isocitrate dehydrogenase NADP+-linked(mitochondrial)
Isocitreto dehydrogonaso NADP!-linked(extramitochondrial)
Isocitrats dehydrogenaro NAD+-linked
oxalaoetste
acotyl-CoA
crS-AConitAts
citreto
isocitrate
isocitrato
ieocitrate
o.26
0.4
no inhibition
mlll
1.6
0,7
mIw
5.0
3.0
2.4
2.0
mM
3.0
3.6
0.28
0.008
0.3
0.05-0.1
3.78
no ofreot
1.6
2.2
no ofroot(slight activation et
low isocitrate)
no inhibition
(sUght activation ot
low irocitrate)
. 
-All lnhlbltors vots oomlletltlve exc,ept thls one, whlch wa8 :rot-oompetitiye.
e.g. aifua,tn sJmthaso, a,conitase and NADP+-linkecl
isooitrate dehydrogenase.
ATP-Citrate Lgase
Competitive inhibition of ATP.citrate lyase by(-)hydroxyeitrate [9] at low conc€ntrations {8 pM)
has been conffrmed in this study. 1,2,3-Tricarboxy-
benzene did not affect'this enzyme (Table 3).
P y r uuate D ehg ilr og ena,s e
As reported proyiously [7,8], pyruvate dehydro-
gen&se prepa,red from rat-liver mitochondria w&g
inhibited oompletely by citrate (4.5 mM, Table 4).
The concentrations of (-)hyilrorycitrate and 1,2,3-
t'ricarboxybenzene required to inhibit
dehydrogenase ryere grc&tot then that required for
citrate (Tablo a). (-)Hydroxycitrate was somewhat
more inhibitory than 1,2,3-tricarboxybenzeno. Siaae
neither inhibitor should be expected to reaoh theso
concentrations insido the mitoohondria, theso in-
hibitors are unlikd to affeot pJrmyate dehydrogen-
ase in intact cell experimenta.
Qenaral Comtnemta
There are major problems with the use of meto-
bolic inhibitors in the study of reguletory phenome-
non. A componnd is required whose site and mode
of action are speaiffe. AIso, the concentlation of this
agent required to aohieve this action should be known
as highor concentrations of these inhibitorr might
have additional sites of aotion.
l,2,S.Tricarboxybenzene is a very pot€nt in-
hibitor of acetyl-CoAoarboxylase (&20 p,M, Fig.l).
Tablg 4. Inhibition ol rot-liaer ,pyrunte dchgdrogenese by
aifrafe. ( 
- 
)hydrotgcitrale ani 1,2,3-triaarbomien*nn
T-ho enzymo 
-was 61st converted to the phosphoiylated (in-aotive) forn by preinoubation in the preeence of i mM ATPfor 30 min at room temperature. Tlhe enzvme was thon
activated in tbe presencebf 10 mM MgCl, aild g mnf CaCls
for 5 min at room tomperature. The dnirol enzyme volu6
was 17.8 f 2.7 nmol fi- r.Clpyruvote+ l&CO" i,u" Z mln.
Tho trica,rboxylates wero adiied to the activa;tio; mixture
and the enzyme was then asoayed 5 min later. Results
represent tho mean + S.E'M, of 4'exporimonts, each oxperi-
mont with quadruplicate obgorvations
ddaltttton of trlc$rboxylatc
to actlYatlon mlxtnto f.f;frX Aouvrty
No adclition (control)
Cit'rata
(- )II-ydroxycitroto (hytlrolyzed
or lactono)
1,2,3 -Tricarboxybonzene 86*84*
7L J:.
0.6
1.6
4.6
0.6
0.6
1.5
4.6
0.6
1.5
4.5
100
77 + 10.8
36 t 11.88
-O + 8.2&
9? * 18.2
97 + 18.2
76 + r7.0
59 { 10.0a
7.2
6.6
8.2a
r ? < 0.01.
ff its eytosolic concontration were to rise to tho mM
range, inhibition of the mitoahondrial citrate trans-porter (Table2), phosphofructokinaso (Tablel),
ext'ramitochondrial NADP+-linkett isocitrato de-
hydrogenase and &e,onitase (Table 3) would occur.
Since this agent is 
"nlikely to enter rat-liver mito-
ahondria (Table 2), one would not ant'icipate direct
efrects on intramitochondrial enzJmes.(-)Eydroxycitratc is a potent inhibitor of ATP-
citrate lyas" (.Kr 8 p,M, Table 3) and has been used
in studies on the control of lipogenesis [11,28-31].
Eigher eSrtosolio concontrations might activate
acetyl-CoA carboxylase (/{" 7001&I, Fig.2) and. also
enter the mitochondrion on the oitrate transporter
(.Kn 350 p.Il{, Table 2). Onee inside the mitoohondrion,
inhibition of NADP+-linked isocitrate dehydrogenase
and aconitase (Table 3) could occur. At coneentra-
tions in the mM range, citrato synthase (Table 3),
p5rmvate dehydrogenase (Table 4) and phospho-
fructokinase {Tablo f ) night also be inhibited.In addition, 1,2,3-t'riaarborybenzene and (-)-
hydroxycitrate, like citrato, can chelato divalent
metel cations liko trflga+, [fns+ and Ca2+ which could
produce other non-specifio metabolic actions.
Concl,rtgi'ons
1,2,3-Tricarboxybenzene may be a suitable agent
to study tho cholegterol biorynthetio pathway in rat
Iiver wit'h fatty acid synthesis inhibiteal. This would
require a eytosolio ooncontration 1,2,3-bioarboxy-
benzeno which was high enough to inhibit acetyl-
CoA carboxylase (K1 approx. 20 pM) but low
enough so as not to inhibit' the mitoohondrial citnate
transporter (Kr approx. 2 nM) or phosphofructo-
kinase (K1 approx. 5 nM). This agent is unlikely
to enter rat-liver mitochondria because it is not a
substrat€ for the citrato transportor.
In gtudies using (-)hydroxycitrato ae a speciff.c
inhibitor of ATP-citrate lyase (fr a,pprox. 8 pM),
activation of aoetyl-CoA carboxylase (Ks approx.
700 prM) and entry into the mitochondrion on tho
citrato transporter (tr- 350 pM) should be considered
in interpreting results. Once insidethe mitochondrion,
this agent could inhibit aconitaso and NADP+-linked
isocitrat€ dehydrogenase (ff1 values 250-280 pM).
Eigh cytosolio ooncentrations could also inhibit
phoaphofructokinase.
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